Cargando…
Development of immune checkpoint therapy for cancer
Since the early 20th century, immunologists have investigated mechanisms that protect vertebrates from damaging immune responses against self-antigens by mature lymphocytes, i.e., peripheral tolerance. These mechanisms have been increasingly delineated at the molecular level, ultimately culminating...
Autores principales: | Fritz, Jill M., Lenardo, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547853/ https://www.ncbi.nlm.nih.gov/pubmed/31068379 http://dx.doi.org/10.1084/jem.20182395 |
Ejemplares similares
-
A guide to cancer immunotherapy: from T cell basic science to clinical practice
por: Waldman, Alex D., et al.
Publicado: (2020) -
Immune checkpoint therapy for pancreatic cancer
por: Johansson, Henrik, et al.
Publicado: (2016) -
Immune checkpoint therapy in liver cancer
por: Xu, Feng, et al.
Publicado: (2018) -
Immune Checkpoint Inhibitors in Cancer Therapy
por: Shiravand, Yavar, et al.
Publicado: (2022) -
Next generation of immune checkpoint therapy in cancer: new developments and challenges
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018)